Polymorphism in intron 2 of the fetal interleukin-1 receptor antagonist genotype influences midtrimester amniotic fluid concentrations of interleukin-1beta and interleukin-1 receptor antagonist and pregnancy outcome

Détails

ID Serval
serval:BIB_C15342D94661
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Polymorphism in intron 2 of the fetal interleukin-1 receptor antagonist genotype influences midtrimester amniotic fluid concentrations of interleukin-1beta and interleukin-1 receptor antagonist and pregnancy outcome
Périodique
American Journal of Obstetrics and Gynecology
Auteur⸱e⸱s
Witkin  S. S., Vardhana  S., Yih  M., Doh  K., Bongiovanni  A. M., Gerber  S.
ISSN
0002-9378 (Print)
Statut éditorial
Publié
Date de publication
11/2003
Volume
189
Numéro
5
Pages
1413-7
Notes
Journal Article
Research Support, U.S. Gov't, P.H.S. --- Old month value: Nov
Résumé
OBJECTIVE: Preterm labor in experimental models is initiated by intra-amniotic interleukin-1beta (IL-1beta) and inhibited by interleukin-1 receptor antagonist (IL-1ra). The IL-1ra gene is polymorphic and the different alleles are associated with variations in IL-1beta and IL-1ra production. The relationship among the IL-1ra genotype of the fetus, concentrations of IL-1beta and IL-1ra in second-trimester amniotic fluid, and pregnancy outcome was determined. STUDY DESIGN: Amniotic fluids from 291 consecutive women with singleton pregnancies, obtained at 15 to 17 weeks' gestation, were tested for IL-1beta and IL-1ra concentrations by enzyme-linked immunosorbent assay. DNA from fetal cells was analyzed for a length polymorphism in intron 2 of the IL-1ra gene by polymerase chain reaction. Pregnancy outcomes were obtained after completion of testing. RESULTS: The distribution of fetal IL-1ra genotypes was similar to that found in other populations: 50.9% (148) were homozygous for allele 1 (IL1RN*1), 39.5% (115) were IL1RN*1/allele 2 (IL1RN*2) heterozygotes, 6.9% (20) were IL1RN*2 homozygotes, whereas 2.7% (8) had combinations of other alleles. Fetal possession of IL1RN*2 was associated with a greater than 50% increase in midtrimester intra-amniotic IL-1beta levels (P=.006) and a smaller increase in IL-1ra levels (P=.01) compared with fetuses who were IL1RN*1 homozygotes. Despite the low sample size, IL1RN*2 homozygosity, but not midtrimester intraamniotic levels of IL-1beta and IL-1ra, was related to an increased rate of preterm birth (P<.0001). In the 11 pregnancies that were subsequently terminated because of major malformations, there was a decreased frequency of IL1RN*1 homozygosity (P=.04). Birth weight was unrelated to IL-1ra genotype. CONCLUSION: Possession by the fetus of the IL1RN*2 allele is associated with enhanced intraamniotic IL-1beta production. Induction of an intra-amniotic proinflammatory immune response might be more likely to lead to preterm labor in fetuses carrying the IL1RN*2 allele.
Mots-clé
Amniotic Fluid/*metabolism Female Fetus/*metabolism Genetic Predisposition to Disease/genetics Genotype Humans Interleukin 1 Receptor Antagonist Protein Interleukin-1/*metabolism *Introns Osmolar Concentration Polymorphism, Genetic/*genetics Pregnancy Pregnancy Outcome Pregnancy Trimester, Second Sialoglycoproteins/*genetics/*metabolism
Pubmed
Web of science
Création de la notice
25/01/2008 15:44
Dernière modification de la notice
20/08/2019 15:36
Données d'usage